Impact of COVID-19 and Nonpharmaceutical Interventions on Common Respiratory Viruses in Children: A 5-Year Study in Hangzhou, China

Background: Nonpharmaceutical Interventions (NPIs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) not only curbed the spread of novel coronavirus (COVID-19) but also affected common respiratory viruses infected by children. Methods: Samples of children diagnosed with respirator...

Full description

Saved in:
Bibliographic Details
Published inIntervirology Vol. 68; no. 1; pp. 24 - 42
Main Authors Zhou, Jianming, Sun, Yanhong, Shen, Hao, Yang, Liuqiao, Ye, Qing, Zhu, Hongmei, Zhu, Zhiwen
Format Journal Article
LanguageEnglish
Published Switzerland S. Karger AG 01.01.2025
Subjects
Online AccessGet full text
ISSN0300-5526
1423-0100
DOI10.1159/000546151

Cover

Loading…
Abstract Background: Nonpharmaceutical Interventions (NPIs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) not only curbed the spread of novel coronavirus (COVID-19) but also affected common respiratory viruses infected by children. Methods: Samples of children diagnosed with respiratory tract infection in Children’s Hospital affiliated with Zhejiang University from January 2019 to December 2023 were collected, and ADV, Flu A, Flu B, and RSV were detected. Statistical analysis was carried out with R software. Results: From January 2019 to December 2023, a total of 684,413 samples were tested, including 369,620 males, accounting for 54.01%, and 314,793 females, accounting for 45.99%. Among them, there were 213,443 positive samples (31.19%), of which 40,484 ADV-positive samples (18.97%), 106,423 Flu A-positive samples (49.86%), 32,379 Flu B-positive samples (15.17%), 30,776 RSV-positive samples (14.42%), and 3,381 mixed infection samples (1.58%). Among children of different ages in Hangzhou before, during and after COVID-19, the highest total detection rate of respiratory virus was 4–6 years old (accounting for 36.69%), followed by >7 years old (accounting for 35.10%). The distribution in different seasons shows that the number of children infected with respiratory viruses reaches a peak in winter and spring. Compared with 2019 (33.20%) before the COVID-19 epidemic, the total detection rate of common respiratory viruses in children was lower during the COVID-19 pandemic (24.54% in 2020–2022), and it was increased in 2023 after NPIs were cancelled (accounting for 35.20%). Conclusion: NPI measures can effectively reduce the spread of common respiratory viruses, Lifting of NPIs can lead children to an increase viral infection rate, particularly in Flu A.
AbstractList Background: Nonpharmaceutical Interventions (NPIs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) not only curbed the spread of novel coronavirus (COVID-19) but also affected common respiratory viruses infected by children. Methods: Samples of children diagnosed with respiratory tract infection in Children’s Hospital affiliated with Zhejiang University from January 2019 to December 2023 were collected, and ADV, Flu A, Flu B, and RSV were detected. Statistical analysis was carried out with R software. Results: From January 2019 to December 2023, a total of 684,413 samples were tested, including 369,620 males, accounting for 54.01%, and 314,793 females, accounting for 45.99%. Among them, there were 213,443 positive samples (31.19%), of which 40,484 ADV-positive samples (18.97%), 106,423 Flu A-positive samples (49.86%), 32,379 Flu B-positive samples (15.17%), 30,776 RSV-positive samples (14.42%), and 3,381 mixed infection samples (1.58%). Among children of different ages in Hangzhou before, during and after COVID-19, the highest total detection rate of respiratory virus was 4–6 years old (accounting for 36.69%), followed by >7 years old (accounting for 35.10%). The distribution in different seasons shows that the number of children infected with respiratory viruses reaches a peak in winter and spring. Compared with 2019 (33.20%) before the COVID-19 epidemic, the total detection rate of common respiratory viruses in children was lower during the COVID-19 pandemic (24.54% in 2020–2022), and it was increased in 2023 after NPIs were cancelled (accounting for 35.20%). Conclusion: NPI measures can effectively reduce the spread of common respiratory viruses, Lifting of NPIs can lead children to an increase viral infection rate, particularly in Flu A.
Nonpharmaceutical Interventions (NPIs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) not only curbed the spread of novel coronavirus (COVID-19) but also affected common respiratory viruses infected by children. Samples of children diagnosed with respiratory tract infection in Children's Hospital affiliated with Zhejiang University from January 2019 to December 2023 were collected, and ADV, Flu A, Flu B, and RSV were detected. Statistical analysis was carried out with R software. From January 2019 to December 2023, a total of 684,413 samples were tested, including 369,620 males, accounting for 54.01%, and 314,793 females, accounting for 45.99%. Among them, there were 213,443 positive samples (31.19%), of which 40,484 ADV-positive samples (18.97%), 106,423 Flu A-positive samples (49.86%), 32,379 Flu B-positive samples (15.17%), 30,776 RSV-positive samples (14.42%), and 3,381 mixed infection samples (1.58%). Among children of different ages in Hangzhou before, during and after COVID-19, the highest total detection rate of respiratory virus was 4-6 years old (accounting for 36.69%), followed by >7 years old (accounting for 35.10%). The distribution in different seasons shows that the number of children infected with respiratory viruses reaches a peak in winter and spring. Compared with 2019 (33.20%) before the COVID-19 epidemic, the total detection rate of common respiratory viruses in children was lower during the COVID-19 pandemic (24.54% in 2020-2022), and it was increased in 2023 after NPIs were cancelled (accounting for 35.20%). NPI measures can effectively reduce the spread of common respiratory viruses, Lifting of NPIs can lead children to an increase viral infection rate, particularly in Flu A.
Author Zhou, Jianming
Sun, Yanhong
Shen, Hao
Zhu, Hongmei
Yang, Liuqiao
Ye, Qing
Zhu, Zhiwen
Author_xml – sequence: 1
  givenname: Jianming
  surname: Zhou
  fullname: Zhou, Jianming
– sequence: 2
  givenname: Yanhong
  surname: Sun
  fullname: Sun, Yanhong
– sequence: 3
  givenname: Hao
  surname: Shen
  fullname: Shen, Hao
– sequence: 4
  givenname: Liuqiao
  surname: Yang
  fullname: Yang, Liuqiao
– sequence: 5
  givenname: Qing
  surname: Ye
  fullname: Ye, Qing
– sequence: 6
  givenname: Hongmei
  surname: Zhu
  fullname: Zhu, Hongmei
– sequence: 7
  givenname: Zhiwen
  surname: Zhu
  fullname: Zhu, Zhiwen
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40294589$$D View this record in MEDLINE/PubMed
BookMark eNpVkUtLxDAUhYMoOo4u_AOSrWA1N03SqRsZxteAOOALXJW0vXUi06QkrTBu_eN2UAddncX57oFzzy7ZtM4iIQfATgBkesoYk0KBhA0yAMHjiAFjm2TAYsYiKbnaIbshvPVYDDHbJjuC8VTIUTogn9O60UVLXUUns-fpRQQp1bakd842c-1rXWDXmkIv6NS26N_RtsbZQJ2lE1fXvdxjaIzXrfNL-mx8FzBQ07tzsyg92jM6pjJ6Qe3pQ9uVy5V3o-3rx9x1xyvK6j2yVelFwP0fHZKnq8vHyU10O7ueTsa3UcET1kZ5ovMKVQpFIvK0UqlCpUtZiVgmABVTOepS5MhHfbcURyCgQAGylKOEI2fxkJx_5zZdXmNZ9F28XmSNN7X2y8xpk_13rJlnr-49Aw5KKq76hMO_CevT33_2wNE3UHgXgsdqjQDLVltl663iLw9Hhi4
Cites_doi 10.1038/s41579-022-00807-9
10.1002/jmv.25069
10.1007/s00705-021-05214-8
10.1038/s41467-021-25120-6
10.1016/j.jinf.2023.01.013
10.1002/jmv.25906
10.1111/irv.13103
10.1016/j.micinf.2021.104911
10.1111/irv.12858
10.1016/S0140-6736(22)00982-5
10.1093/nsr/nwac004
10.1002/jmv.27570
10.1038/s41467-021-27292-7
10.1017/ice.2021.495
10.1098/rsos.211883
10.15585/mmwr.mm7029a1
10.1002/jmv.28292
10.7150/ijbs.59374
10.4103/jgid.jgid_138_23
10.1093/cid/ciab942
10.1111/ajt.16381
10.1093/cid/ciaa1328
10.3389/fped.2021.721005
10.1186/s12985-021-01627-8
10.1038/s41467-021-23440-1
10.1016/S0140-6736(22)00478-0
10.3390/v15051160
10.1093/cid/ciaa1458
10.1038/s41598-024-84586-8
10.1002/jmv.24047
10.1016/j.jcv.2021.104795
10.7189/jogh.11.05007
10.3389/fmicb.2022.938372
10.1056/NEJMoa2001017
10.1016/j.physrep.2021.02.001
ContentType Journal Article
Copyright 2025 The Author(s). Published by S. Karger AG, Basel.
2025 The Author(s). Published by S. Karger AG, Basel 2025
Copyright_xml – notice: 2025 The Author(s). Published by S. Karger AG, Basel.
– notice: 2025 The Author(s). Published by S. Karger AG, Basel 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
5PM
DOI 10.1159/000546151
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Impact of COVID-19 and NPIs on Common Respiratory Viruses in Children
EISSN 1423-0100
EndPage 42
ExternalDocumentID PMC12165626
40294589
10_1159_000546151
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
-~X
0~B
326
36B
3O.
4.4
5GY
5RE
AAYIC
AAYXX
ABBTS
ABPAZ
ABWCG
ACGFS
ACGOD
ACPRK
ACPSR
ADBBV
ADFRT
AENEX
AEYAO
AHFRZ
AHMBA
ALDHI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZPMC
BENPR
CITATION
CS3
DU5
E0A
EBS
EMB
EMOBN
F5P
FB.
GROUPED_DOAJ
HCIFZ
HZ~
IAO
IY7
KUZGX
L7B
M--
M7P
N9A
O1H
O9-
OK1
RKO
SV3
UJ6
.GJ
0~5
29J
30W
34G
39C
3O-
53G
7X7
88E
88I
8AF
8AO
8FE
8FH
8FI
8FJ
8UI
ABJNI
ABUWG
ACQXL
ADAGL
AFFNX
AFJJK
AFKRA
AFSIO
AI.
AIOBO
AZQEC
BBNVY
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
CGR
COF
CUY
CVF
CYUIP
DWQXO
ECM
EIF
EJD
FYUFA
GNUQQ
HMCUK
IHR
INH
ITC
LK8
M1P
M2P
NPM
OHT
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
RIG
RXVBD
S0X
UKHRP
VH1
ZGI
ZXP
5PM
ID FETCH-LOGICAL-c270t-b7abfe691c74b9f696e6ad5f435711f06bead4be289459e8141ce415d5872e203
ISSN 0300-5526
IngestDate Thu Aug 21 18:27:43 EDT 2025
Mon Jul 21 05:47:04 EDT 2025
Thu Jul 03 08:24:47 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Respiratory syncytial virus
Influenza B virus
Influenza A virus
Adenovirus
2019 coronavirus disease
Respiratory tract infection in children
Language English
License https://creativecommons.org/licenses/by-nc/4.0
2025 The Author(s). Published by S. Karger AG, Basel.
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c270t-b7abfe691c74b9f696e6ad5f435711f06bead4be289459e8141ce415d5872e203
OpenAccessLink http://dx.doi.org/10.1159/000546151
PMID 40294589
PageCount 19
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_12165626
pubmed_primary_40294589
crossref_primary_10_1159_000546151
PublicationCentury 2000
PublicationDate 2025-01-01
PublicationDateYYYYMMDD 2025-01-01
PublicationDate_xml – month: 01
  year: 2025
  text: 2025-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel, Switzerland
PublicationTitle Intervirology
PublicationTitleAlternate Intervirology
PublicationYear 2025
Publisher S. Karger AG
Publisher_xml – name: S. Karger AG
References ref13
ref35
ref12
ref34
ref15
ref14
ref31
ref30
ref11
ref33
ref10
ref32
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – ident: ref10
  doi: 10.1038/s41579-022-00807-9
– ident: ref23
  doi: 10.1002/jmv.25069
– ident: ref14
  doi: 10.1007/s00705-021-05214-8
– ident: ref13
  doi: 10.1038/s41467-021-25120-6
– ident: ref27
  doi: 10.1016/j.jinf.2023.01.013
– ident: ref35
  doi: 10.1002/jmv.25906
– ident: ref5
  doi: 10.1111/irv.13103
– ident: ref29
  doi: 10.1016/j.micinf.2021.104911
– ident: ref11
  doi: 10.1111/irv.12858
– ident: ref25
  doi: 10.1016/S0140-6736(22)00982-5
– ident: ref30
  doi: 10.1093/nsr/nwac004
– ident: ref2
  doi: 10.1002/jmv.27570
– ident: ref8
  doi: 10.1038/s41467-021-27292-7
– ident: ref28
  doi: 10.1017/ice.2021.495
– ident: ref31
  doi: 10.1098/rsos.211883
– ident: ref21
  doi: 10.15585/mmwr.mm7029a1
– ident: ref6
  doi: 10.1002/jmv.28292
– ident: ref7
  doi: 10.7150/ijbs.59374
– ident: ref34
  doi: 10.4103/jgid.jgid_138_23
– ident: ref12
  doi: 10.1093/cid/ciab942
– ident: ref16
  doi: 10.1111/ajt.16381
– ident: ref18
  doi: 10.1093/cid/ciaa1328
– ident: ref19
  doi: 10.3389/fped.2021.721005
– ident: ref1
  doi: 10.1186/s12985-021-01627-8
– ident: ref20
  doi: 10.1038/s41467-021-23440-1
– ident: ref32
  doi: 10.1016/S0140-6736(22)00478-0
– ident: ref24
  doi: 10.3390/v15051160
– ident: ref3
  doi: 10.1093/cid/ciaa1458
– ident: ref9
  doi: 10.1038/s41598-024-84586-8
– ident: ref26
  doi: 10.1002/jmv.24047
– ident: ref4
  doi: 10.1016/j.jcv.2021.104795
– ident: ref15
  doi: 10.7189/jogh.11.05007
– ident: ref22
  doi: 10.3389/fmicb.2022.938372
– ident: ref33
  doi: 10.1056/NEJMoa2001017
– ident: ref17
  doi: 10.1016/j.physrep.2021.02.001
SSID ssj0003130
Score 2.3837721
Snippet Background: Nonpharmaceutical Interventions (NPIs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) not only curbed the spread of novel...
Nonpharmaceutical Interventions (NPIs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) not only curbed the spread of novel coronavirus...
SourceID pubmedcentral
pubmed
crossref
SourceType Open Access Repository
Index Database
StartPage 24
SubjectTerms Adolescent
Child
Child, Preschool
China - epidemiology
COVID-19 - epidemiology
COVID-19 - prevention & control
Female
Humans
Infant
Infant, Newborn
Influenza A virus - isolation & purification
Influenza B virus - isolation & purification
Influenza, Human - epidemiology
Influenza, Human - prevention & control
Influenza, Human - virology
Male
Respiratory Syncytial Virus Infections - epidemiology
Respiratory Syncytial Virus, Human - isolation & purification
Respiratory Tract Infections - epidemiology
Respiratory Tract Infections - prevention & control
Respiratory Tract Infections - virology
SARS-CoV-2
Title Impact of COVID-19 and Nonpharmaceutical Interventions on Common Respiratory Viruses in Children: A 5-Year Study in Hangzhou, China
URI https://www.ncbi.nlm.nih.gov/pubmed/40294589
https://pubmed.ncbi.nlm.nih.gov/PMC12165626
Volume 68
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFLaGIiQuiJ1hk4U4Yogd24m5VQU0U0E50FYtl1GccZgcSMowOdArv4H_y_MSN2E4FC5R5GWsyfv09veM0HMNUluXqSJZWTDCtVFEibIgmVR6qTnjRWoLhT8cyNkR3z8RJ5PJr0HWUrfRL8vzv9aV_A9VYQzoaqtk_4Gy8UdhAN6BvvAECsPzUjSexxLHvY_H8zeEKhcLOGibs9XIVT0fZDa6-ICtC2md8z4G2o_rdffdpWf5fsf2thVXti7Iqe3288m1n7atsYrmy_mq7Xy0Ply_3Su4_qR6PfLWfw6r9wGLX3tZ6SJRjuedFs2qHYyGgpFZ0UaeFLza7-vuWx2Gg6uCiYGrIpRoJQkRgoXe157jgj4Hi5JkyJJlvgW9wF_5QFL7tlzbMkAonzQpuFXXLgRdH9z_Q_7FrERnDwm1iFuvoKsMrA_aW-pBwKfUXWET_01oWAVbX8WtIzUn6jbjvNuBInN4E90IFgje9XC6hSamuY2u-TtJf9xBPz2ocFvhHlQYQIW3QIVHoMJtgz2o8ABUOIAK1zAbQPUa72IPKewgZed6SL3ADlB30dG7t4d7MxJu6iAly5IN0VmhKyMVLTOuVSWVNLJYigp08YzSKpEaGBYwArDuuVAmp5yWBlTHpcgzZliS3kM7TduYBwjLqtS6WibGpIJreFeZkIZZQZTnlWRT9Kz_sIsz35BlsUW4Kbrvv3RcwhMGR-dqivIRDeIC22Z9PNPUK9dunTLboYrJh5c5-RG6foH8x2hns-7ME1BbN_qpA9Fvjy-YQg
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+COVID-19+and+Nonpharmaceutical+Interventions+on+Common+Respiratory+Viruses+in+Children%3A+A+5-Year+Study+in+Hangzhou%2C+China&rft.jtitle=Intervirology&rft.au=Zhou%2C+Jianming&rft.au=Sun%2C+Yanhong&rft.au=Shen%2C+Hao&rft.au=Yang%2C+Liuqiao&rft.date=2025-01-01&rft.issn=0300-5526&rft.eissn=1423-0100&rft.volume=68&rft.issue=1&rft.spage=24&rft.epage=42&rft_id=info:doi/10.1159%2F000546151&rft.externalDBID=n%2Fa&rft.externalDocID=10_1159_000546151
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-5526&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-5526&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-5526&client=summon